Activating de novo mutations in NFE2L2 encoding NRF2 cause a multisystem disorder
The NRF2 transcription factor regulates the response to stress in mammalian cells. Here, the authors show that activating mutations in NRF2, commonly found in cancer cells, are found in four patients with a multisystem disorder characterized by immunodeficiency and neurological symptoms.
Guardado en:
Autores principales: | Peter Huppke, Susann Weissbach, Joseph A. Church, Rhonda Schnur, Martina Krusen, Steffi Dreha-Kulaczewski, W. Nikolaus Kühn-Velten, Annika Wolf, Brenda Huppke, Francisca Millan, Amber Begtrup, Fatima Almusafri, Holger Thiele, Janine Altmüller, Peter Nürnberg, Michael Müller, Jutta Gärtner |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/afa5f18f07b548228b00ab048e187a66 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Integrated analysis of patients with KEAP1/NFE2L2/CUL3 mutations in lung adenocarcinomas
por: Xing Jin, et al.
Publicado: (2021) -
Elevated expression of NFE2L3 promotes the development of gastric cancer through epithelial-mesenchymal transformation
por: Xiaodong Wang, et al.
Publicado: (2021) -
MicroRNA-1246 Mediates Drug Resistance and Metastasis in Breast Cancer by Targeting NFE2L3
por: Yue-chu Dai, et al.
Publicado: (2021) -
CNC-bZIP protein NFE2L1 regulates osteoclast differentiation in antioxidant-dependent and independent manners
por: Zhiyuan Liu, et al.
Publicado: (2021) -
The cytoprotective role of DJ-1 and p45 NFE2 against human primary alveolar type II cell injury and emphysema
por: Li Hui Tan, et al.
Publicado: (2018)